Bio-Key International opened lower at $2.47, compared with its previous close of $2.48. In the last trading session, the stock traded between $2.42 and $2.57. It showed an upward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Bio-Key International is now worth
$ 0.46
Resulting in a loss of
$ 99.54 (99.54%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
+$0.08 (+3.23%)
Day High
$2.57
Day Low
$2.42
Day Open
$2.47
Prev Close
$2.48
Volume
83,924
1W Return
8.80%
1M Return
56.48%
3M Return
-34.11%
6M Return
-51.79%
1Y Return
-68.86%
Fundamentals
Market Cap ($ Mn)
4
PE Ratio
-
PB Ratio
0.76
PEG Ratio
-
ROE
-483.43%
ROCE
-347.29%
EPS (TTM)
$-0.53
Investment Returns
1 Week
8.80%
1 Month
56.48%
3 Months
-34.11%
6 Months
-51.79%
9 Months
-58.03%
Financials
Quarterly
All values in $ Mn
1.6
Mar 25
1.7
Jun 25
1.5
Sep 25
1.1
Dec 25
2.1
Mar 26
1.9
Jun 26
Updates
7Nov
BIO-key International sets Q3 2026 earnings release for Nov 13
BIO-key International releases Q3 2026 results on November 13, 2026. Investor call scheduled for 10:00 am ET led by CEO Mike DePasquale. Webcast replay available for three months post-event.
6 days ago
13Oct
Bio-key appoints Stephen Morrow as President of PortalGuard
Stephen Morrow appointed President of PortalGuard, succeeding Mark Cochran who retired after 20 years. Morrow brings experience from AirMDR, Devo, Flexera, and Verizon to drive IAM solution adoption. Appointment aligns with Bio-key's push for passwordless and FIDO-certified Passkey:YOU solutions. Leadership change targets growth in enterprise and channel partner segments amid AI-driven security threats.
1mo ago
10Oct
BIO-key International files prospectus for resale of 1.24 million shares
BIO-key International filed a prospectus with the SEC. The filing covers the resale of up to 1,236,668 common shares. The shares are being offered by a selling stockholder.
